Release Date: 07/07/10 15:28 Summary: Recapitalisation Progress Report Price Sensitive: No Download Document 132.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%